NGFR and glioma: In that study, we found that p75NTR was expressed in 22% mid-grade astrocytomas (two of nine) and 85% of glioblastoma multiforme (GBM) specimens (17 of 20), and that the p75NTR-positive glioma cells in the patient tumor cell population were more migratory than the p75NTR-negative glioma cells.